- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-52/09 R: Order of the President of the Court of First Instance of 24 April 2009 — Nycomed Danmark v EMEA (Application for interim measures — Marketing authorisation for a medicinal product — Ultrasound echocardiographic imaging agent for diagnostic purposes (perflubutane) — Refusal by the EMEA to grant a waiver from the obligation to submit a paediatric investigation plan — Application for suspension of operation of a measure and interim measures — No urgency)
ECLI:EU:UNKNOWN:62009TB0052
62009TB0052
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 141/43
(Case T-52/09 R)
(Application for interim measures - Marketing authorisation for a medicinal product - Ultrasound echocardiographic imaging agent for diagnostic purposes (perflubutane) - Refusal by the EMEA to grant a waiver from the obligation to submit a paediatric investigation plan - Application for suspension of operation of a measure and interim measures - No urgency)
2009/C 141/91
Language of the case: English
Parties
Applicant: Nycomed Danmark ApS (Roskilde, Denmark) (represented by: C. Schoonderbeek and H. Speyart van Woerden, lawyers)
Defendant: European Medicines Agency (EMEA) (represented by: V. Salvatore and N. Rampal Olmedo, Agents)
Re:
APPLICATION, first, for suspension of the operation of the EMEA’s decision of 28 November 2008 rejecting the application for a product-specific waiver concerning perflubutane and, secondly, for the grant of interim measures.
Operative part of the order
1.The application for interim measures is dismissed.
2.Costs are reserved.